PCM
TNDM icon

Penn Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Penn Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-44,214
Closed -$3.39M – 305
2016
Q3 		$3.39M Sell
44,214
-132
-0.3% -$9.63K 0.23% 129
2016
Q2 		$3.34M Sell
44,346
-12
-0% -$966 0.19% 146
2016
Q1 		$3.86M Sell
44,358
-901
-2% -$78.8K 0.22% 141
2015
Q4 		$5.34M Buy
45,259
+177
+0.4% +$17.6K 0.24% 131
2015
Q3 		$3.97M Buy
45,082
+13,853
+44% +$1.61M 0.21% 171
2015
Q2 		$3.38M Buy
+31,229
New +$3.88M 0.14% 197

Other funds holding TNDM

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Penn Capital Management's TNDM Position: Q4 2016 in Review

Penn Capital Management sold out of Tandem Diabetes Care (TNDM) in Q4 2016, closing a stake of 44,214 shares — an estimated $3.39M sold.

Penn Capital Management first reported a position in TNDM in Q2 2015 and held it in 6 quarters. The position peaked at $5.34M in Q4 2015. 75 funds tracked by Wall St. Rank hold TNDM as of Q4 2016.

  • Penn Capital Management reported no remaining Tandem Diabetes Care position as of Q4 2016 after selling out during the quarter.
  • Penn Capital Management sold 44,214 Tandem Diabetes Care shares in Q4 2016, an estimated $3.39M.
  • Penn Capital Management first reported a position in Tandem Diabetes Care in Q2 2015 and held it in 6 quarters.
  • Penn Capital Management's Tandem Diabetes Care position peaked at $5.34M in Q4 2015.
  • 75 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2016.

Based on Penn Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.